EMEA-000774-PIP01-09-M03
Key facts
Invented name |
Eviplera
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0274/2018
|
PIP number |
EMEA-000774-PIP01-09-M03
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Gilead Sciences International Ltd
E-mail: regulatory.pip@gilead.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|